Evidence map›Paper›PMID 42090241›Full record

ReviewAmerican journal of reproductive immunology (New York, N.Y. : 1989)2026

Beyond the Barrier: Epithelial Cells as Immune Sentinels in the Female Genital Tract.

Lauren Jirik, Shreya Joshi, Aisha Nazli, Charu Kaushic

Abstract readReview
In one paragraph

Review in American journal of reproductive immunology (New York, N.Y. : 1989), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Special Issue on New Horizons in HIV and Reproductive Health Research.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Article
  2. The Gut-Vagina Axis.Microorganisms · 2026
    Review
  3. Beyond the Barrier: Epithelial Cells as Immune Sentinels in the Female Genital Tract.American journal of reproductive immunology (New York, N.Y. : 1989) · 2026
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lauren JirikMcMaster Immunology Research Centre, Michael G. DeGroote Centre For Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.ORCID 0009-0000-2738-5041
Shreya JoshiMcMaster Immunology Research Centre, Michael G. DeGroote Centre For Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0001-9209-0397
Aisha NazliMcMaster Immunology Research Centre, Michael G. DeGroote Centre For Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.
Charu KaushicMcMaster Immunology Research Centre, Michael G. DeGroote Centre For Learning and Discovery, McMaster University, Hamilton, Ontario, Canada.ORCID 0000-0002-7088-2569

Funding

CIHR #159229Dr. Charu Kaushic
6 · The paper itself

Abstract

Epithelial cells (ECs) of the female genital tract (FGT) serve as an essential barrier and the first line of defense against sexually transmitted pathogens. Beyond providing a physical barrier, these cells actively contribute to immune responses through pathogen recognition, cytokine release, and modulation of adaptive immune responses. Sexually transmitted viruses such as HIV-1 and HSV-2 must overcome the physical and functional barriers of the mucosal surface to establish infection. This review explores the intricate relationship between genital ECs and HIV-1 and HSV-2, emphasizing on how these interactions influence infection outcomes. We examine the innate immune responses of ECs in the upper and lower FGT, highlighting both their similarities and differences. Additionally, we delve into the mechanisms of pathogen recognition and virus-specific innate immune responses of genital ECs to HIV-1 and HSV-2. Deepening our understanding of epithelial-viral interactions is critical for identifying key determinants of susceptibility and resistance to sexually transmitted infections (STIs). Elucidating these mechanisms is essential for developing targeted strategies to enhance mucosal immunity, through novel antiviral therapies, vaccine strategies, or interventions to fortify epithelial defenses. Such advancements have the potential to improve protection against these infections and reduce their global burden.

Indexed as

Epithelial CellsGenitalia, FemaleHerpes GenitalisHerpesvirus 2, HumanHIV-1HIV InfectionsSexually Transmitted DiseasesAnimalsFemaleHumansImmunity, InnateImmunity, Mucosalepithelial cellsfemale genital tractHIV‐1HSV‐2immune responsessexually transmitted infections

Identifiers

PMID42090241
PMCPMC13148466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.